MxHero, Inc., today announced extended offerings in support of the Life Sciences industry tied to recent announcements by cloud content management company, Box

SAN FRANCISCO, CA, UNITED STATES, March 6, 2018 /EINPresswire.com/ -- "The Life Sciences sector of the U.S. economy stands to benefit tremendously by the innovations taking place with today's cloud content management platforms", said Alex Panagides, co-founder and CEO of mxHero, Inc. "As enterprises across the spectrum set the stage for 21st Century digitization, we're seeing strong adoption within the life science's sector when it comes to intelligent content routing, governance, security, and collaboration leveraging leading cloud content management platforms when combined with mxHero's Mail2Cloud solution. With the MxHero platform, principal investigators, research firms, research cohorts and CRO-aligned teams have elected to define content not only as content at rest placed into cloud-based containers, rather these organizations are looking to exploit advanced digital, meta-data, intelligent routing, collaboration and AI-based context and sentiment solutions targeting in-flight content as well. This approach applies to both regulated and unregulated content. When you can do that with one CCM platform, it's game changing. With some 40% of enterprise content unfortunately flowing through email systems, with the Mail2Cloud solution platform, mxHero clients are able to fully capitalize on the security, governance and content collaboration objectives they strive for - including content that today flows through email. mxHero's Mail2Cloud solution, when combined with the world's leading cloud content management solutions such as Box, is of tremendous value to research and Life Sciences organizations that are seeking new and better ways to increase their productivity through digital, secure and content-based collaboration technologies."

With Box's announcement in February 2018, life sciences professionals can transform the way they collaborate and work across their entire ecosystem, all while maintaining GxP compliance and adherence to other industry standards. "With mxHero's Mail2Cloud platform, these same professionals can extend these game-changing CCM capabilities to their vital email-based content and communications to drive further cohort research engagement, improve collaboration among Principal Investigators and do this in a manner that is secure and compliant. It's simply game changing and will fuel the industry's ability to save lives while becoming more efficient, secure and collaborative." said Alex Panagides.

"We're excited to provide GxP Validation within Box, and to our extended network of partners like mxHero, so that customers can seamlessly manage both unregulated and regulated content in one centralized cloud content management platform," said Riju Khetarpal, Managing Director, Box for Life Sciences. "With GxP Validation, companies in regulated industries can eliminate inefficient silos between regulated and unregulated information, and speed up collaboration and innovation."

About MxHero
MxHero's products and services gives companies, service providers and end users powerful new ways to control, use and analyze email-based content. Apps developed for MxHero's platform work with any email management program, including Gmail, O365 and Microsoft Exchange. MxHero is the 2016 Box Elite Partner of the Year and provides solutions mapped to the world's foremost cloud and hybrid content management platforms including Box. Information on all of their Mail2Cloud product line can be found at http://www.mail2cloud.io. More than 3,500 companies with over 1 million users have added MxHero to their email. To learn more about MxHero visit http://www.mxHero.com. Find MxHero on Twitter: @mxHeronet and Facebook: MxHero.net

Bruno Santos
MxHero Inc.
4159428211
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.